Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD

B. Sposato, M. Salvatore, M. M. Giovanna, R. Alberto, C. Elena, G. Aldo, M. Lia, P. Piero, F. Clemente (Grosseto, Roma, Italy)

Source: Annual Congress 2005 - COPD - treatment III
Session: COPD - treatment III
Session type: Thematic Poster Session
Number: 1959
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Sposato, M. Salvatore, M. M. Giovanna, R. Alberto, C. Elena, G. Aldo, M. Lia, P. Piero, F. Clemente (Grosseto, Roma, Italy). Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD. Eur Respir J 2005; 26: Suppl. 49, 1959

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acute effect of formoterol, salmeterol, albuterol, oxitropium bromide and placebo on FEV1, inspiratory capacity and dyspnoea in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 380s
Year: 2001

Influence of higher than conventional doses of salbutamol or ipratropium bromide on bronchodilation induced by a regular treatment with tiotropium in patients suffering from stable COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 356s
Year: 2007

Sleep architecture in COPD patients during salmeterol versus tiotropium bromide treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 199s
Year: 2006

Salmeterol or ipratropium bromide/fenoterol in stable mild-to-moderate COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 426s
Year: 2001

Sleep architecture in COPD patients during salmeterol versus ipratropium bromide treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 113s
Year: 2004

Influence of tiotropium bromide and formoterol on bronchial hyperresponsiveness in COPD
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


The efficacy of long-acting anticholinergic agent, tiotropium bromide on dynamic hyperinflation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 429s
Year: 2006

Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD
Source: Eur Respir J 2001; 17: 1132-1137
Year: 2001



A comparison of bronchodilating response of salbutamol, ipratropium bromide and the combination of ipratropium-salbutamol in patients with stable chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 59s
Year: 2001

A comparison of early bronchodilating responses of Salbutamol, Ipratropium bromide, and the combination of Ipratropium bromide-Salbutamol in stable patients with COPD or asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 253s
Year: 2001

Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD
Source: Eur Respir J 2004; 23: 825-831
Year: 2004



Effects of tiotropium bromide on bronchial obstruction and exercise tolerance in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006

Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 108s
Year: 2002

Comparison of nebulized ipratropium bromide with salbutamol versus salbutamol alone in acute asthma exacerbation in children
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

The combination therapy with inhaled tiotropium bromide and transdermal tulobuterol in COPD improves the peripheral airway function
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010

Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Comparative study of two years treatment with salmeterol alone and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004

Lung function response to budesonide and ipratropium bromide in COPD patients who continue smoking
Source: Eur Respir J 2002; 20: Suppl. 38, 245s
Year: 2002

Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010